Key result
Ambulatory veno-venous extracorporeal membrane oxygenation is safe and prevents critical illness neuropathy and myopathy during prolonged treatments in the intensive care unit.
Ambulatory VV ECMO is a safe strategy that allows patients with severe respiratory failure to exercise, preventing critical illness neuropathy and myopathy during prolonged ICU stays.
Ambulatory VV ECMO may mitigate ICU-acquired weakness in respiratory failure; leaves open confirmation in prospective trials.
Veno-venous extracorporeal membrane oxygenation (VV ECMO) is used for support in patients with severe respiratory failure. The method allows extracorporeal gas exchange and may replace the patient's lung function for weeks and even years. ECMO is not a contraindication for lung transplant. The most important factor for a good outcome is the physiological status of the patient when accepted for transplantation. Ambulatory ECMO makes it possible for the patient to exercise and walk, and provides the best outcome for high risk patients in severe respiratory failure. Ambulatory ECMO is safe in the hands of skilled personnel and prevents critical illness neuropathy and myopathy during prolonged treatments in the intensive care unit.
No takes yet. Share an insight, caveat, or question.
Jonas Andersson Lindholm (2018) conducted a review in Severe respiratory failure. Ambulatory veno-venous extracorporeal membrane oxygenation (VV ECMO) was evaluated. Ambulatory veno-venous extracorporeal membrane oxygenation is safe and prevents critical illness neuropathy and myopathy during prolonged treatments in the intensive care unit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: